Nautilus Biotechnology, Inc.
USD2.58
-0.10 (-3.73%)
CEO
Sujal Patel
IPO Date
2020-08-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.68
Prev. Close
$2.68
Day Low
$2.58
Day High
$2.71
52W Low
$0.62
52W High
$4.31
Market Cap
$0.33B
Volume
0.36M
| 160,000 |
| $2.32 |
| 4 Mar 2026 | Mallick Parag | director, 10 percent owner, officer: Chief Scientist | A-Award | Acquired | 280,000 | $2.32 |
| 4 Mar 2026 | Patel Sujal M | director, 10 percent owner, officer: CEO, President, and Secretary | A-Award | Acquired | 650,000 | $2.32 |
| 4 Mar 2026 | Sankar Subramanian | Senior VP, Product Development | A-Award | Acquired | 160,000 | $2.32 |
| 4 Mar 2026 | Weld Gwen E | Chief People Officer | A-Award | Acquired | 160,000 | $2.32 |
| 4 Mar 2026 | Murphy Matthew B. | General Counsel | A-Award | Acquired | 160,000 | $2.32 |
| 4 Mar 2026 | Suzuki Kentaro | Chief Marketing Officer | A-Award | Acquired | 160,000 | $2.32 |
| 10 Nov 2025 | Suzuki Kentaro | Chief Marketing Officer | P-Purchase | Acquired | 4,000 | $1.49 |
| 9 Sept 2025 | Patel Sujal M | director, 10 percent owner, officer: CEO, President, and Secretary | P-Purchase | Acquired | 116,500 | $0.67 |